Rick Costantino is CTO and co-founder of
Group14 Technologies, the world’s leading commercial manufacturer and supplier
of advanced silicon battery technology for consumer electronics, electric vehicles and more. Group14
is ushering in the silicon battery era with its transformational material,
SCC55™, which is bringing the power of AI to the forefront of personal
computing and our increasingly mobile lives. Group14 is rapidly scaling its
global manufacturing capabilities to help address the growing demand for
energy.
Rick has more than 30 years of
experience developing stable, high-performance products at the molecular level,
spanning chemical and biopharmaceutical industries for companies such as
Genentech, Alkermes, and Nastech.
Rick’s efforts have culminated in numerous
commercial products, from marketed therapeutics to electrode materials for
advanced ultracapacitors and lead acid batteries. Rick holds more than 60 U.S. patents and
has more than 50 publications. Prior to founding Group14, he served as the VP
of research and development at EnerG2. Previously, Rick served as the CSO of
delivery at MDRNA Inc. and CSO at G2B Pharma. Rick holds a Ph.D. in Chemical
Engineering from M.I.T. and a B.S. and M.S. in Chemical Engineering from Johns
Hopkins University.